• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛带绦虫:用重组六钩蚴抗原对牛进行囊尾蚴病疫苗接种。

Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens.

作者信息

Lightowlers M W, Rolfe R, Gauci C G

机构信息

Molecular Parasitology Laboratory, University of Melbourne, Werribee, Victoria, Australia.

出版信息

Exp Parasitol. 1996 Dec;84(3):330-8. doi: 10.1006/expr.1996.0121.

DOI:10.1006/expr.1996.0121
PMID:8948322
Abstract

Taenia saginata is a medically and economically important cestode parasite. Infection with the cysticercus larval stage in cattle causes economic loss in the beef meat industry. A practical vaccine to prevent infection with the parasite in cattle would be valuable and would assist in control of transmission of the parasite to humans, the obligate definitive host. Here we use recombinant DNA techniques to clone oncosphere antigens of T. saginata and use the recombinant antigens in vaccine trials in cattle. Vaccination with a combination of two antigens, designated TSA-9 and TSA-18, induced up to 99.8% protection against experimental challenge infection with T. saginata eggs. Operational characteristics of the vaccine will need to be defined, such as duration of immunity and protection of newborn calves. The vaccine has the potential to be used on a commercial scale for the control of bovine cysticercosis.

摘要

牛带绦虫是一种在医学和经济方面都很重要的绦虫寄生虫。牛感染囊尾蚴幼虫阶段会给牛肉行业造成经济损失。一种实用的预防牛感染该寄生虫的疫苗将很有价值,并且有助于控制该寄生虫向其终末宿主——人类的传播。在此,我们运用重组DNA技术克隆牛带绦虫六钩蚴抗原,并将重组抗原用于牛的疫苗试验。用两种名为TSA - 9和TSA - 18的抗原组合进行疫苗接种,可诱导产生高达99.8%的针对牛带绦虫虫卵实验性攻击感染的保护作用。需要确定该疫苗的操作特性,如免疫持续时间和对新生犊牛的保护作用。这种疫苗有潜力用于商业规模的牛囊尾蚴病防控。

相似文献

1
Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens.牛带绦虫:用重组六钩蚴抗原对牛进行囊尾蚴病疫苗接种。
Exp Parasitol. 1996 Dec;84(3):330-8. doi: 10.1006/expr.1996.0121.
2
Vaccination for the prevention of cysticercosis.用于预防囊尾蚴病的疫苗接种。
Dev Biol (Basel). 2004;119:361-8.
3
Studies on the development of DNA vaccine against Cysticercus cellulosae infection and its efficacy.抗猪囊尾蚴感染DNA疫苗的研制及其效果研究。
Southeast Asian J Trop Med Public Health. 2001;32 Suppl 2:105-10.
4
Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.用重组六钩蚴抗原疫苗诱导对猪囊尾蚴病的保护作用。
Infect Immun. 2004 Sep;72(9):5292-7. doi: 10.1128/IAI.72.9.5292-5297.2004.
5
Cysticercosis: identification and cloning of protective recombinant antigens.囊尾蚴病:保护性重组抗原的鉴定与克隆
J Parasitol. 1996 Apr;82(2):250-4.
6
Vaccination against cysticercosis and hydatid disease.针对囊尾蚴病和包虫病的疫苗接种。
Parasitol Today. 2000 May;16(5):191-6. doi: 10.1016/s0169-4758(99)01633-6.
7
Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens.使用天然和重组六钩蚴抗原来对猪进行猪带绦虫囊尾蚴病疫苗接种。
Int J Parasitol. 1999 Apr;29(4):643-7. doi: 10.1016/s0020-7519(99)00021-1.
8
Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A.针对猪带绦虫囊尾蚴病疫苗TSOL18和TSOL45-1A的抗体反应及表位特异性
Parasite Immunol. 2006 May;28(5):191-9. doi: 10.1111/j.1365-3024.2006.00820.x.
9
Vaccines against cysticercosis and hydatidosis.抗囊尾蚴病和包虫病疫苗。
Vet Parasitol. 2001 Nov 22;101(3-4):337-52. doi: 10.1016/s0304-4017(01)00559-3.
10
Ag-ELISA and PCR for monitoring the vaccination of cattle against Taenia saginata cysticercosis using an oncospheral adhesion protein (HP6) with surface and secreted localization.使用具有表面和分泌定位的六钩蚴粘附蛋白(HP6),通过抗原捕获酶联免疫吸附测定法(Ag-ELISA)和聚合酶链反应(PCR)监测牛抗牛带绦虫囊尾蚴病疫苗接种情况。
Trop Anim Health Prod. 2005 Feb;37(2):103-20. doi: 10.1023/b:trop.0000048459.98067.99.

引用本文的文献

1
Taenia saginata prevalence in cattle slaughtered at low throughput abattoirs in South Africa.南非低产量屠宰场屠宰牛的牛带绦虫感染率
Onderstepoort J Vet Res. 2024 Dec 4;91(1):e1-e8. doi: 10.4102/ojvr.v91i1.2157.
2
Mining gene expression data for rational identification of novel drug targets and vaccine candidates against the cattle tick, Rhipicephalus microplus.从基因表达数据中挖掘新的药物靶点和疫苗候选物,以对抗牛蜱,即 Rhipicephalus microplus。
Exp Appl Acarol. 2023 Oct;91(2):291-317. doi: 10.1007/s10493-023-00838-8. Epub 2023 Sep 27.
3
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections.
mRNA 疫苗技术时代与寄生虫感染的未来防控。
Clin Microbiol Rev. 2023 Mar 23;36(1):e0024121. doi: 10.1128/cmr.00241-21. Epub 2023 Jan 10.
4
Optimal control analysis of bovine cysticercosis and human taeniasis.牛囊尾蚴病和人体绦虫病的最优控制分析
Parasite Epidemiol Control. 2021 Dec 31;16:e00236. doi: 10.1016/j.parepi.2021.e00236. eCollection 2022 Feb.
5
Molecular tools-advances, opportunities and prospects for the control of parasites of veterinary importance.分子工具——控制具有兽医重要性的寄生虫的进展、机遇与前景
Int J Trop Insect Sci. 2021;41(1):33-42. doi: 10.1007/s42690-020-00213-9. Epub 2020 Jul 29.
6
Molecular characterization of the Taenia solium Tso31 antigen and homologous of other Taenia species from Peru.来自秘鲁的猪带绦虫Tso31抗原及其他带绦虫物种同源物的分子特征分析。
Parasitol Res. 2019 Apr;118(4):1307-1309. doi: 10.1007/s00436-018-06195-5. Epub 2019 Jan 9.
7
Engineering DNA vaccines against infectious diseases.工程化针对传染病的 DNA 疫苗。
Acta Biomater. 2018 Oct 15;80:31-47. doi: 10.1016/j.actbio.2018.08.033. Epub 2018 Aug 31.
8
Development of the multi-epitope chimeric antigen rqTSA-25 from Taenia saginata for serological diagnosis of bovine cysticercosis.从带绦虫多表位嵌合抗原 rqTSA-25 的研发看牛囊尾蚴病血清学诊断。
PLoS Negl Trop Dis. 2018 Apr 12;12(4):e0006371. doi: 10.1371/journal.pntd.0006371. eCollection 2018 Apr.
9
Human taeniasis: current insights into prevention and management strategies in endemic countries.人体绦虫病:流行国家预防和管理策略的当前见解
Risk Manag Healthc Policy. 2017 Jun 1;10:107-116. doi: 10.2147/RMHP.S116545. eCollection 2017.
10
Analysis of codon usage pattern in Taenia saginata based on a transcriptome dataset.基于转录组数据集的牛带绦虫密码子使用模式分析
Parasit Vectors. 2014 Dec 2;7:527. doi: 10.1186/s13071-014-0527-1.